Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-006850
Filing Date
2017-02-01
Accepted
2017-02-01 18:13:58
Documents
1
Period of Report
2017-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8353
  Complete submission text file 0001209191-17-006850.txt   9751
Mailing Address C/O IDENIX PHARMACEUTICALS, INC. 60 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address
Macdonald Guy (Reporting) CIK: 0001296998 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35837 | Film No.: 17566136

Mailing Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472
Business Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Issuer) CIK: 0001373707 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations